Organisation paid for research Program year 2024 Source: CMS Open Payments

Klein and Associates, M D , PA

Neither a doctor nor a teaching hospital

Research payments

$37,317

7 payments

Through program year 2024, Klein and Associates, M D , PA is reported as receiving $37,317 in research payments, across 7 payments.

By program year

4 rows
Year Kind Amount Payments
2024 Research $5,687 2
2023 Research $21,328 2
2022 Research $10,198 2
2021 Research $103 1

Breakdown

Who paid Research payments · program years 2021–2024
  1. E.R. Squibb & Sons, L.L.C. $37,317 7 payments
Studies the money was for Research payments · program years 2021–2024
  1. AMPLIFIED Study - A Randomized, Head-to-head, Single-blind Study to Compare the Response to Treatment with Subcutaneous Abatacept vs Adalimumab, on Background Methotrexate, in Adults with Early, Seropositive Rheumatoid Arthritis Who Have "Shared Epitope $13,506 1 payment
  2. AMPLIFIED - A Randomized, Head-to-head, Single-blind Study to Compare the Response to Treatment with Subcutaneous Abatacept vs Adalimumab, on Background Methotrexate, in Adults with Early, Seropositive Rheumatoid Arthritis Who Have "Shared Epitope" HLA Cl $10,048 1 payment
  3. Phase III PsA #2 - A Multi-center, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants with Active Psoriatic Arthritis (PsA) who are Naive to Biologic Disease Modifying Anti-rhe $7,972 2 payments
  4. A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Na ve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNF? Inhibitor Treatment $3,245 1 payment
  5. A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate $2,442 1 payment
  6. AMPLIFIED Study $103 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record